Meet Sandra Silvestri, Chief Medical Officer, Executive Vice
“What drives me is the opportunity to shape medicineand clinical practice that reaches beyond the individual – to improve outcomes for entire communities. As a physician, I’ve seen the difference the right treatment and appropriate care can make. Now, I have the privilege of helping to shape clinical practice and bring those treatments to more people,faster than ever before.”
Sandra joined Ipsen in 2023, bringing over 20 years of global clinical and medical leadership from academia, hospitals and pharmaceutical companies like Sanofi and Eli Lilly. She is a physician specialized in endocrinology and metabolic diseases and holds aPh.D. in internal medicine and cardiovascular disease.In addition to her industry leadership, Sandra is also a published researcher, professor, and advocate for gender equity in science. At Ipsen, she leads theGlobal Medical Organization, encompassing the portfolio Therapeutic strategy, Clinical Operations, Patient Safety and Patient Affairs and more, with a strong focus on patient-centric innovation. Since joining Ipsen, she has led a bold transformation to position medical affairs as a best-in-class function —advancing Ipsen’s strategy to integrate science, real-world evidence, and patient insights throughout the product lifecycle to accelerate access to innovation.
Learn More About Sandra Silvestri
Meet Christelle Huguet, Executive Vice President, R&D
“I came to science because I was curious – I loved askingquestions and finding answers in the data. It’s not alwayssmooth, but the challenges are worth it when you know thegoal is helping people. We’re all patients at some point.Using science to make a difference, whether today ortomorrow, is a privilege that motivates me every day.”
Christelle joined Ipsen in 2020 with extensive experience indrug discovery and development across multipletherapeutic areas, having held senior scientific roles at X-Chem, Alexion, and Pfizer. She holds a Ph.D. in Molecularand Cellular Biology from the Pasteur Institute. At Ipsen,Chriselle leads R&D from discovery through late-stagedevelopment across Oncology, Rare Disease, andNeuroscience, and is also accountable for the company’sExternal Innovation strategy. Since joining, she hastransformed and expanded the portfolio to build strongfranchises including Ipsen’s leading work in rare liverdiseases, and expanding Ipsen’s early developmentpipeline into new areas – featuring best and first-in classassets in pioneering modalities such as Antibody DrugConjugates and T Cell Engagers. Key achievements includeadvancing multiple assets into Phase I and beyond andaccelerating innovation by successfully guiding key datareadouts and driving 7 major regulatory approvals.
Learn More About Christelle HuguetOur partnerships define who we are at Ipsen
Philippe Lopes-Fernandes, EVP, Chief Business Officer on how true collaboration paves the way to innovation.
Our acceleration defines who we are at Ipsen
Christelle Huguet, EVP, Head of Research and Development on harnessing technology to accelerate the journey from discovery to innovative medicine.
A Life in Science
How science gives you our people a purpose. What is it like to work at the forefront of innovation? From lab discoveries to patient impact, hear directly from the people making it happen. Explore stories from our global R&D and medical teams and see how purpose drives every step of the journey.
Partnering
Our people are the heart of our science, but innovation happens through collaboration. Ipsen’s partnerships span from basic research to clinical development, working with external partners to unlock new possibilities.
Learn more